Virology Research Today is a free monthly online journal that collates and summarizes the latest research about Virology, including details on viruses, pathology, classification, definitions.

Volume 5 (2009), Issue 4 (April)

1. Effectiveness and safety of simplification from tenofovir-lamivudine (TDF-3TC) to tenofovir-emtricitabine (TDF-FTC) co-formulation (Truvada) in virologically suppressed HIV-infected patients on HAART.
   Eur J Clin Microbiol Infect Dis, 28(4): 399-402. [Abstract] [Full-text]
2. Safety of Switching Nevirapine Twice Daily to Nevirapine Once Daily in Virologically Suppressed Patients.
   J Acquir Immune Defic Syndr, 50(4): 390-6. [Abstract] [Full-text]
3. Early serum HBsAg drop: a strong predictor of sustained virological response to pegylated interferon alfa-2a in HBeAg-negative patients.
   Hepatology, 49(4): 1151-7. [Abstract] [Full-text]
4. Hepatitis C virus virology and new treatment targets.
   Expert Rev Anti Infect Ther, 7(3): 329-50. [Abstract] [Full-text]
5. Effect of HIV-1 subtype on virologic and immunologic response to starting highly active antiretroviral therapy.
   Clin Infect Dis, 48(9): 1296-305. [Abstract] [Full-text]
6. Impact of hepatitis B exposure on sustained virological response rates of highly viremic chronic hepatitis C patients.
   Gastroenterol Res Pract, 2009: 812140. [Abstract] [Full-text]
7. Efficacy and safety of switching from boosted lopinavir to boosted atazanavir in patients with virological suppression receiving a LPV/r-containing HAART: the ATAZIP study.
   J Acquir Immune Defic Syndr, 51(1): 29-36. [Abstract] [Full-text]
8. Antiretroviral therapy adherence, virologic and immunologic outcomes in adolescents compared with adults in southern Africa.
   J Acquir Immune Defic Syndr, 51(1): 65-71. [Abstract] [Full-text]
9. Frequent detection of hepatitis B virus DNA in hepatocellular carcinoma of patients with sustained virologic response for hepatitis C virus.
   J Med Virol, 81(6): 1009-14. [Abstract] [Full-text]
10. Tumour virology--history, status and future challenges.
    APMIS, 117(5): 382-99. [Abstract] [Full-text]
11. Dried-plasma transport using a novel matrix and collection system for human immunodeficiency virus and hepatitis C virus virologic testing.
    J Clin Microbiol, 47(5): 1491-6. [Abstract] [Full-text]

© 2005-2010 Virology Research Today. All Rights Reserved.